Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone turnover and biochemical markers in malignancy

J A Kanis1, E V McCloskey

  • 1World Health Organization Collaborating Centre for Metabolic Bone Diseases, University of Sheffield Medical School, United Kingdom.

Cancer
|November 15, 1997
PubMed
Summary

Neoplasia disrupts bone remodeling through increased turnover, resorption-formation imbalance, and uncoupling, leading to skeletal deficits or osteosclerosis. Bone turnover markers, like pyridinium crosslinks, aid in prognosis and treatment monitoring.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of FRAXplus adjustments on fracture risk reclassification in older Swedish women-results from the SUPERB-study.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2025
Same author

A surrogate FRAX model for Mongolia.

Archives of osteoporosis·2025
Same author

Conflating the Operational Definition of Osteoporosis with Intervention Thresholds.

Calcified tissue international·2025
Same author

A surrogate FRAX model for Nepal.

Archives of osteoporosis·2024
Same author

An overview of the use of the fracture risk assessment tool (FRAX) in osteoporosis.

Journal of endocrinological investigation·2023
Same author

Previous fracture and subsequent fracture risk: a meta-analysis to update FRAX.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2023

Area of Science:

  • Oncology
  • Orthopedics
  • Metabolic Bone Disease

Background:

  • Neoplasia frequently impacts skeletal integrity through distinct bone remodeling disturbances.
  • These disturbances include increased bone turnover, resorption-formation imbalance, and uncoupling, affecting both localized metastases and generalized skeletal health.

Purpose of the Study:

  • To elucidate the principal disturbances in bone remodeling associated with skeletal neoplasia.
  • To explore the potential of skeletal markers in diagnosing, prognosing, and monitoring bone metastases.

Main Methods:

  • Review of existing literature on bone remodeling in the context of cancer metastasis.
  • Assessment of various skeletal markers, focusing on pyridinium crosslinks for their predictive value.

Related Experiment Videos

Main Results:

  • Three primary bone remodeling abnormalities in skeletal neoplasia are identified: increased turnover, resorption-formation imbalance, and uncoupling.
  • Pyridinium crosslinks demonstrate high specificity but low sensitivity for diagnosing bone metastases, limiting their utility in initial detection.
  • Skeletal markers are valuable for assessing disease progression and response to treatments like bisphosphonates, despite limitations in daily monitoring precision.

Conclusions:

  • Understanding the cellular mechanisms of bone remodeling abnormalities in cancer is crucial.
  • Skeletal markers, particularly pyridinium crosslinks, offer insights into disease natural history and treatment efficacy, though diagnostic sensitivity remains a challenge.